Harrow Health
Stock Forecast, Prediction & Price Target
Harrow Health (HROW) stock Price Target by analysts
$64
Potential upside: 69.31%
Harrow Health price prediction
What is Harrow Health stock analysts` prediction?
Harrow Health stock forecast: Based on 2 Wall Street analysts` predicted price targets for Harrow Health in the last 3 months, the avarage price target is $64, with a high forecast of $NaN. The average price target represents a 69.31% change from the last price of $37.8.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Harrow Health stock Price Target by analysts
Full breakdown of analysts given Harrow Health price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Sahil Kazmi B.Riley Financial | 0% 0/1 | 11 months ago | $73 93.12% upside | $56.41 | StreetInsider | Previous targets (0) |
Brooks O’Neil Lake Street | 0% 0/2 | 12 months ago | $55 45.50% upside | $49.75 | TheFly | Previous targets (1) |
Chase Knickerbocker Craig-Hallum | 0% 0/2 | about 1 year ago | $45 19.04% upside | $35.25 | TheFly | Previous targets (1) |
Chase Knickerbocker Craig-Hallum | 0% 0/2 | about 1 year ago | $30 -20.63% downside | $19.93 | TheFly | Previous targets (1) |
Brooks O’Neil Lake Street | 0% 0/2 | over 1 year ago | $25 -33.86% downside | $18.13 | TheFly | Previous targets (1) |
Brooks O'Neil Loop Capital Markets | 0% 0/1 | over 1 year ago | $25 -33.86% downside | $17.68 | StreetInsider | Previous targets (0) |
Harrow Health Financial Estimates
Harrow Health Revenue Estimates
Harrow Health EBITDA Estimates
Harrow Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $72.47M N/A | $88.59M 22.24% | $130.19M 46.95% | Avg: $268.85M Low: $265.28M High: $274.07M avg. 106.50% | Avg: $350.18M Low: $345.53M High: $356.98M avg. 30.25% | Avg: $441.50M Low: $435.64M High: $450.08M avg. 26.07% | |
Net Income
% change YoY
| $-18.00M N/A | $-14.08M 21.77% | $-24.41M -73.29% | Avg: $26.33M Low: $17.93M High: $25.44M avg. 207.89% | Avg: $86.42M Low: $62.50M High: $65.20M avg. 228.14% | Avg: $103.72M Low: $101.93M High: $106.34M avg. 20.01% | |
EBITDA
% change YoY
| $2.11M N/A | $1.91M -9.13% | $9.72M 406.67% | Avg: $11.55M Low: $11.40M High: $11.78M avg. 18.89% | Avg: $15.05M Low: $14.85M High: $15.34M avg. 30.25% | Avg: $18.98M Low: $18.73M High: $19.35M avg. 26.07% | |
EPS
% change YoY
| -$0.67 N/A | -$0.51 23.88% | -$0.75 -47.05% | Avg: $0.68 Low: $0.55 High: $0.78 avg. 191.11% | Avg: $1.95 Low: $1.92 High: $2 avg. 185.36% | Avg: $3.18 Low: $3.13 High: $3.26 avg. 63.07% | |
Operating Expenses
% change YoY
| $52.39M N/A | $61.29M 16.97% | $90.12M 47.03% | Avg: $169.47M Low: $167.22M High: $172.77M avg. 88.05% | Avg: $220.74M Low: $217.81M High: $225.03M avg. 30.25% | Avg: $278.31M Low: $274.62M High: $283.72M avg. 26.07% | |
FAQ
What is Harrow Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 152.01% in 2025-2027.
We have gathered data from 2 analysts. Their low estimate is 17.93M, average is 26.33M and high is 25.44M.
What is Harrow Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 54.27% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is $265.28M, average is $268.85M and high is $274.07M.
What is Harrow Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 146.51% in 2025-2027.
We have gathered data from 2 analysts. Their low earnings per share estimate is $0.55, average is $0.68 and high is $0.78.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Harrow Health stock. The most successful analyst is Sahil Kazmi.